AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2014
Mar 17, 2014
35066_dirs_2014-03-17_a528070b-4df3-4c9b-a2be-21d8bd0097df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOZONE PHARMACEUTICALS, INC. (BZNE)
CIK: 0001412486
Period of Report: 2014-03-17
Reporting Person: McGuire Gerald A (N/A)
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15